Name
Osaühing Pharmac MS
Registry code
10082312
VAT number
EE100159071
Type
OÜ - Limited Liability Company
Status
Registered
Foundation date
21.10.1996 (28)
Financial year
01.01-31.12
Capital
72 800.00 €
Activity
68201 - Rental and operating of own or leased real estate 46461 - Wholesale of medicines and other pharmacy goods
-
-
-
-
-
-
Not submitted
No tax arrears
-
-
| Owner | Representative | Beneficial owner | Roles | |
|---|---|---|---|---|
| Omanikukonto: TÕNIS ALTSAAR 13.05.1957 (67) | 92% - 67 080.00 EUR | Board member | Direct ownership | |
| Omanikukonto: ELERI JÜRIMÄE 09.09.1968 (56) | 4% - 3 120.00 EUR | - | - | |
| Lii Oll 05.11.1956 (68) | 4% - 2 600.00 EUR | - | - |
| 2019 20.10.2020 | 2020 02.08.2021 | 2021 07.10.2022 | 2022 10.05.2023 | |
|---|---|---|---|---|
| Total Revenue | 3 172 052 € | 3 023 012 € | 2 691 409 € | 2 474 191 € |
| Net profit (loss) for the period | 132 907 € | 142 650 € | 133 690 € | 126 792 € |
| Profit Margin | 4% | 5% | 5% | 5% |
| Current Assets | 2 565 755 € | 2 697 002 € | 2 833 397 € | 2 997 007 € |
| Fixed Assets | 712 092 € | 694 861 € | 690 974 € | 661 159 € |
| Total Assets | 3 277 847 € | 3 391 863 € | 3 524 371 € | 3 658 166 € |
| Current Liabilities | 83 179 € | 54 545 € | 53 363 € | 60 366 € |
| Non Current Liabilities | - | - | - | - |
| Total Liabilities | - | - | - | - |
| Share Capital | - | - | - | - |
| Equity | 3 194 668 € | 3 337 318 € | 3 471 008 € | 3 597 800 € |
| Employees | 11 | 12 | 12 | 12 |
| Turnover | State taxes | Labor taxes and payments | Employees | |
|---|---|---|---|---|
| 2024 Q1 | 753 830.08 € | 51 155.53 € | 16 911.02 € | 12 |
| 2023 Q4 | 764 672.4 € | 35 963.84 € | 15 987.03 € | 11 |
| 2023 Q3 | 663 378.08 € | 42 338.03 € | 16 125.59 € | 12 |
| 2023 Q2 | 768 640.25 € | 49 834.15 € | 17 241.03 € | 12 |
| 2023 Q1 | 879 927.23 € | 52 979.55 € | 17 395.11 € | 12 |
| 2022 Q4 | 770 086.21 € | 49 082.96 € | 17 932.59 € | 12 |
| 2022 Q3 | 664 502.31 € | 45 921.11 € | 18 550.75 € | 12 |
| 2022 Q2 | 875 021.82 € | 43 313.76 € | 17 272.47 € | 12 |
| 2022 Q1 | 914 687.49 € | 47 891.21 € | 17 069.67 € | 12 |
| 2021 Q4 | 961 641.85 € | 50 667.28 € | 16 881.42 € | 13 |
| 2021 Q3 | 854 530.45 € | 50 739.9 € | 17 441.45 € | 13 |
| 2021 Q2 | 855 253.23 € | 48 485.3 € | 16 834.7 € | 13 |
| 2021 Q1 | 827 558.83 € | 49 657.08 € | 16 801.35 € | 13 |
| 2020 Q4 | 1 039 634.58 € | 47 675.11 € | 16 959.83 € | 13 |
| 2020 Q3 | 925 651.33 € | 51 385.84 € | 16 337.49 € | 13 |
| 2020 Q2 | 1 116 164.26 € | 42 862.07 € | 15 985.95 € | 12 |
| 2020 Q1 | 929 985.11 € | 37 106.56 € | 16 009.59 € | 12 |
